News | April 27, 2015

HealthMyne Inc. Receives NSF Grant for Novel Oncology Imaging Analytics Platform

Startup’s first commercial product will target lung cancer screening

April 27, 2015 — HealthMyne Inc. received a Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The grant is for almost $750,000, with a potential to receive an additional $500,000 in Phase IIB funding.

“The overall thrust of our proposal centers on treating the visible evidence of cancer in medical images, not just as pictures, but as mineable data that can be compared across similar cases,” stated Roger Chylla, Ph.D., chief technology officer of HealthMyne and the project’s principal investigator. “Clinical research over the last decade has demonstrated that nodules (early-stage tumors) have reproducible features linked to the probability that they are malignant and/or resistant to certain treatments. For patient care to be improved by these insights, doctors need clinical tools that seamlessly incorporate this evidence into their everyday image interpretation.”

HealthMyne’s first commercial product will be targeting lung cancer screening. Lung cancer causes more deaths in the United States than the next three most common cancers combined; however, studies have shown that the associated mortality rate can significantly improve when detected early.

This specific award was the second phase of a grant submitted as part of NSF’s efforts to foster smart health technologies. According to Jesus Soriano, M.D., Ph.D., program director of SBIR/STTR at NSF, “These categorical proposals must demonstrate an ability to transform healthcare from reactive, hospital-centered, and indemnity-based to proactive, person-centered, preventive, and cost-efficient.”

At the National Science Foundation (NSF), Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) is an approximately $160 million program that catalyzes the commercialization of high-risk technological innovations via research and development grants to small businesses and startups.

For more information:

Related Content

Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
ACR LI-RADS Steering Committee Releases New Version of CT/MRI LI-RADS
News | Clinical Decision Support | August 13, 2018
August 13, 2018 — The American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) steering commit
Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
Technology | Clinical Decision Support | August 08, 2018
Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its...
Metro Health-University of Michigan Health Partners With Eon to Improve Lung Cancer Care
News | Oncology Diagnostics | August 07, 2018
Metro Health-University of Michigan Health announced it is partnering with healthcare data company Eon to improve the...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
computed tomography brain scan

Image courtesy of Pixabay

News | Clinical Trials | July 19, 2018
The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
Overlay Init